The approach was guided by insights from human genetics demonstrating that loss of function variants of SLC39A8 linked to CDG and Leigh syndrome and common variants linked to autoimmune, neurologic, and metabolic diseases reduces systemic Mn levels (4–6, 32). Here, SLC39A8 is linked to metabolic disease.